A plain language summary of the phase 1/2 study of AAV5-hRKp.RPGR (botaretigene sparoparvovec) in people with RPGR-associated X-linked retinitis pigmentosa
Bibliographic record
Abstract
Plain Language SummaryWhat is this summary about?This plain language summary describes the results of a study published in the American Journal of Ophthalmology in 2024. The study looked at a new gene therapy for X-linked retinitis pigmentosa (XLRP), a severe inherited eye disease caused by a change in the retinitis pigmentosa GTPase regulator (RPGR for short) gene. Changes in RPGR cause the breakdown of cells in the retina of the eye, leading to significant vision problems. AAV5hRKp.RPGR (botaretigene sparoparvovec; bota-vec) is an investigational therapy designed to deliver a working copy of the RPGR gene. This may help repair the retina and improve vision in XLRP. In this three-part study, researchers evaluated the safety and effectiveness of different doses of bota-vec in participants with XLRP over 52 weeks.What were the key results?A total of 45 participants received bota-vec gene therapy. Thirteen participants started treatment at Week 26, which allowed researchers to compare treated and untreated participants. Of the 45 treated participants, 37 experienced at least one side effect before Week 26. Most side effects were considered mild or moderate and related to the surgery required to receive the therapy. Participants who received bota-vec had improvements in vision and function of the retina compared with participants who were untreated until Week 26.What do the results mean?Participants generally found that bota-vec had an acceptable safety profile and was well tolerated, and it trended toward visual improvements. These positive results supported investigation of bota-vec in a larger study in participants with XLRP.How to say (download PDF and double click sound icon to play sound)…Botaretigene sparoparvovec: boh-tah-REH-tih-jeen spar-oh-PAR-voh-vekPhotoreceptor: foh-toh-ree-SEP-terRetina: RET-uh-nuhRetinitis pigmentosa: reh-tuh-NIGH-tis pig-men-TOH-suhThis is an abstract of the Plain Language Summary of Publication article.View the full Plain Language Summary PDF of this article to read the full-textLink to original article hereTrial registration: ClinicalTrials.gov identifier: NCT03252847.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".